CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 28 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $94,000 | -89.6% | 31,827 | -94.8% | 0.00% | -100.0% |
| Q1 2020 | $906,000 | +11.9% | 611,297 | +47.9% | 0.01% | +25.0% |
| Q4 2019 | $810,000 | +84.5% | 413,295 | +1122.7% | 0.00% | +100.0% |
| Q1 2018 | $439,000 | +240.3% | 33,802 | +12.8% | 0.00% | +100.0% |
| Q1 2017 | $129,000 | -38.9% | 29,969 | -1.4% | 0.00% | 0.0% |
| Q1 2015 | $211,000 | – | 30,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |